These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37328184)

  • 1. Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials.
    Hong H; Friedland A; Hu M; Anstrom KJ; Halabi S; McKinnon JE; Amaravadi R; Rojas-Serrano J; Abella BS; Portillo-Vázquez AM; Woods CW; Hernandez AF; Boulware DR; Naggie S; Rajasingham R
    BMJ Open; 2023 Jun; 13(6):e065305. PubMed ID: 37328184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
    Schilling WHK; Mukaka M; Callery JJ; Llewelyn MJ; Cruz CV; Dhorda M; Ngernseng T; Waithira N; Ekkapongpisit M; Watson JA; Chandna A; Nelwan EJ; Hamers RL; Etyang A; Beg MA; Sow S; Yavo W; Allabi AC; Basnyat B; Sharma SK; Amofa-Sekyi M; Yonga P; Adler A; Yuentrakul P; Cope T; Thaipadungpanit J; Rienpradub P; Imwong M; Abdad MY; Blacksell SD; Tarning J; Goudjo FF; Dossou AD; Konaté-Touré A; Assi SB; Ouffoué K; Nasronudin N; Rachman BE; Romadhon PZ; Dewanto DD; Heryana MO; Novi T; Pasaribu AP; Mutiara M; Nasution MPR; Khairunnisa K; Dalimunthe FA; Airlangga E; Fahrezzy A; Subronto Y; Ananda NR; Rahardjani M; Rimainar A; Lucinde RK; Timbwa M; Onyango OE; Agutu C; Akech S; Hamaluba M; Kipyego J; Ngachi O; Haidara FC; Traoré OY; Diarra F; Khanal B; Dahal P; Shrestha S; Rijal S; Kabore Y; Adehossi E; Guindo O; Qamar FN; Kazi AM; Woodrow CJ; Laird S; Cheeba M; Ayles H; Cheah PY; Taylor WRJ; Batty EM; Chotivanich K; Pukrittayakamee S; Phumratanaprapin W; von Seidlein L; Dondorp A; Day NPJ; White NJ;
    PLoS Med; 2024 Sep; 21(9):e1004428. PubMed ID: 39264960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; Ferreira LC; Heimfarth L; Araújo AAS; Quintans-Júnior LJ
    Lancet Reg Health Am; 2021 Oct; 2():100062. PubMed ID: 34485970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).
    Naggie S; Milstone A; Castro M; Collins SP; Lakshmi S; Anderson DJ; Cahuayme-Zuniga L; Turner KB; Cohen LW; Currier J; Fraulo E; Friedland A; Garg J; George A; Mulder H; Olson RE; O'Brien EC; Rothman RL; Shenkman E; Shostak J; Woods CW; Anstrom KJ; Hernandez AF;
    Int J Infect Dis; 2023 Apr; 129():40-48. PubMed ID: 36682681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
    Kumar J; Jain S; Meena J; Yadav A
    J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
    Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
    JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial.
    Llanos-Cuentas A; Schwalb A; Quintana JL; Delfin B; Alvarez F; Ugarte-Gil C; Guerra Gronerth RI; Lucchetti A; Grogl M; Gotuzzo E
    BMC Res Notes; 2023 Feb; 16(1):22. PubMed ID: 36849996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis.
    Faruqui AR; Xavier D; Kamat SK; Chandy SJ; Medhi B; Tripathi RK; Shetty YC; Raj JM; Kaushal S; Balakrishnan S; Atal S; Tripathi SK; Badyal DK; Dikshit H; Roy SS; Trivedi N; Chatterjee S; Desai C; Tripathi CD; Rege NN; Gupta P; Raveendran R; Kaul R; Kshirsagar NA
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):219-226. PubMed ID: 33818480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
    Mehta S; Bhandari S; Mehta S
    J Glob Antimicrob Resist; 2020 Sep; 22():864-865. PubMed ID: 32777441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Kashour Z; Kashour T; Gerberi D; Tleyjeh IM
    Clin Transl Sci; 2021 May; 14(3):1101-1112. PubMed ID: 33606894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses.
    Bruce P; Ainscough K; Hatter L; Braithwaite I; Berry LR; Fitzgerald M; Hills T; Brickell K; Cosgrave D; Semprini A; Morpeth S; Berry S; Doran P; Young P; Beasley R; Nichol A
    Trials; 2022 Jun; 23(1):534. PubMed ID: 35761370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection.
    Yadav RM; Pate A; Shankarkumar A; Athalye S; Shinde S; Bargir UA; Pate M; Ganpule M; Pruthi M; Patil H; Madkaikar MR
    J Epidemiol Glob Health; 2021 Sep; 11(3):283-288. PubMed ID: 34514761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions.
    Souza Botelho M; Bolfi F; Leite RGOF; Leite MSF; Banzato LR; Soares LT; Olivatti TOF; Mangolim AS; Oliveira FRK; Abbade LPF; Abbade JF; de Barros Almeida RAM; Simões Corrêa Galendi J; Thabane L; Dos Santos Nunes-Nogueira V
    Syst Rev; 2021 Nov; 10(1):294. PubMed ID: 34736537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of hydroxychloroquine for treatment of mild SARS-CoV-2 infection and prevention of COVID-19 severity in pregnant and postpartum women: A randomized, double-blind, placebo-controlled trial.
    González R; Goncé A; Gil MDM; Mazarico E; Ferriols-Pérez E; Toro P; Llurba E; Saéz E; Rodríguez-Zambrano MÁ; García-Otero L; López M; Santacruz B; Román MÁ; Payà A; Alonso S; Cruz-Lemini M; Pons-Duran C; Herrera LB; Chen H; Bardají A; Quintó L; Menendez C;
    Acta Obstet Gynecol Scand; 2024 Mar; 103(3):602-610. PubMed ID: 38098221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.